Neogen Corporation v. Neo Gen Screening, Inc.

282 F.3d 883, 61 U.S.P.Q. 2d (BNA) 1845, 2002 U.S. App. LEXIS 3478, 2002 WL 341028
CourtCourt of Appeals for the Sixth Circuit
DecidedMarch 6, 2002
Docket00-2107
StatusPublished
Cited by407 cases

This text of 282 F.3d 883 (Neogen Corporation v. Neo Gen Screening, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Neogen Corporation v. Neo Gen Screening, Inc., 282 F.3d 883, 61 U.S.P.Q. 2d (BNA) 1845, 2002 U.S. App. LEXIS 3478, 2002 WL 341028 (6th Cir. 2002).

Opinion

OPINION

RONALD LEE GILMAN, Circuit Judge.

In April of 2000, Neogen Corp. (Neo-gen), a Michigan corporation, filed suit in the Western District of Michigan against Neo Gen Screening, Inc. (NGS), a Pennsylvania corporation, alleging (1) trademark infringement, (2) federal dilution and unfair competition, (3) violation of the Michigan Consumer Protection Act, (4) violation of the Michigan Pricing and Advertising Act, and (5) unjust enrichment. The district court dismissed the suit in August of 2000 for lack of personal jurisdiction over NGS pursuant to Rule 12(b)(2) of the Federal Rules of Civil Procedure. Neogen has appealed. For the reasons set forth below, we REVERSE the judgment of the district court and REMAND the case for further proceedings consistent with this opinion.

I. BACKGROUND

Neogen is in the business of developing and marketing a range of health care, food, and animal-related products and services, including certain diagnostic test kits. Its principal place of business is in Lansing, Michigan, but Neogen also has places of business in Florida, Illinois, and Kentucky. Neogen alleges that it has used the “Neogen” name and trademark continuously and extensively in interstate commerce, and that it has registered the mark with the U.S. Patent and Trademark Office. Its website is found at www.neo-gen.com.

NGS performs diagnostic testing of blood samples from newborn infants. A closely-held Pennsylvania corporation, NGS has its sole place of business in Pittsburgh. Approximately ninety percent of the 215,000 tests that NGS performed in 1999 were generated through contracts with hospitals and governmental agencies around the world, none of which were located in Michigan. The remainder of the tests performed by NGS in 1999 were done at the request of individual physicians or coroners with whom NGS did not have a prior contract. Such customers not under contract can obtain testing services by telephoning or e-mailing NGS to request information and “filter blood collection forms.” NGS then mails the collection form to the customer, who collects the sample and sends it back to the company in a preaddressed return envelope for testing. The customer can then obtain the test results through the mail, or on NGS’s website with a password provided by the *887 company. Customers pay for the tests by mailing a check to NGS’s Pittsburgh office. NGS tested 14 blood samples from Michigan coroners in 1999, and anticipated about the same number for 2000. In earlier years, NGS also received and tested an undisclosed number of samples from Michigan residents.

NGS’s only continuous advertising is through its website, www.neogensereen-ing.com. The website provides information about NGS’s services, lists the e-mail addresses of personnel, and allows prospective customers to print blood-collection forms to be mailed along with blood samples to Pittsburgh. NGS’s website is internationally accessible. Neogen claims-that NGS’s contacts with Michigan through its website and its approximately 14 yearly mail-order transactions with Michigan customers subject NGS to the jurisdiction of the United States District Court -for the Western District of Michigan.

Based upon its conclusion that the exercise of personal jurisdiction over NGS would violate due process, the district court granted NGS’s motion to dismiss pursuant to Rule 12(b)(2) of the Federal Rules of Civil Procedure. The district court made its determination without first conducting an evidentiary hearing. Neo-gen appeals the dismissal. Because the district court granted NGS’s motion to dismiss, it did not consider NGS’s motion to transfer venue on grounds of forum non conveniens pursuant to 28 U.S.C. § 1404(a).

II. ANALYSIS

A.Subject matter jurisdiction

The district court had subject matter jurisdiction over this case based upon diversity of citizenship pursuant to 28 U.S.C. § 1332. Although the district court also had subject matter jurisdiction over the federal trademark, dilution, and unfair competition claims pursuant to 28 U.S.C. § 1331, and supplemental jurisdiction over the state-law claims pursuant to 28 U.S.C. § 1367, both the parties and the district court have treated this case as though jurisdiction were based solely on diversity of citizenship. We will therefore do the same for the purposes of this appeal.

B. Burden of proof

As the plaintiff, Neogen has the burden of establishing the district court’s personal jurisdiction over NGS. Nationwide Mut’l Ins. Co. v. Tryg Int’l Ins. Co., Ltd., 91 F.3d 790, 793 (6th Cir.1996). Because the district court did not conduct an evidentiary hearing on the issue of personal jurisdiction in considering NGS’s motion to dismiss pursuant to Rule 12(b)(2) of the Federal Rules of Civil Procedure, Neogen “need only make a prima facie showing of jurisdiction.” CompuServe, Inc. v. Patterson, 89 F.3d 1257, 1262 (6th Cir.1996). Neogen can meet this burden by “establishing with reasonable particularity sufficient contacts between [NGS] and the forum state to support jurisdiction.” Provident Nat’l Bank v. California Fed. Savings Loan Ass’n, 819 F.2d 434, 437 (3d Cir.1987). Under these circumstances, this court will not consider facts proffered by the defendant that conflict with those offered by the plaintiff, Serras v. First Tenn. Bank Nat’l Ass’n, 875 F.2d 1212, 1214 (6th Cir.1989), and will construe the facts in the light most favorable to the nonmoving party in reviewing a dismissal pursuant to Rule 12(b)(2). Id.

C. The district court erred in concluding that Neogen failed to present a prima facie case of personal jurisdiction over NGS

1 .Standard of review

We review de novo a dismissal for lack of personal jurisdiction pursuant *888 to Rule 12(b)(2) of the Federal Rules of Civil Procedure. Nationwide Mut’l Ins. Co., 91 F.3d at 793. A federal court’s exercise of personal jurisdiction in a diversity of citizenship case must be both (1) authorized by the law of the state in which it sits, and (2) in accordance with the Due Process Clause of the Fourteenth Amendment. Reynolds v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Robert Braun v. Bearman Industries, LLC
Court of Appeals of Kentucky, 2024
Enhanceworks, Inc. v. Dropbox, Inc.
Court of Appeals of Tennessee, 2019
Sarvint Technologies, Inc. v. OMsignal, Inc.
161 F. Supp. 3d 1250 (N.D. Georgia, 2015)
SFS Check, LLC v. First Bank of Delaware
774 F.3d 351 (Sixth Circuit, 2014)
Nasser Beydoun v. Wataniya Restaurants Holding
768 F.3d 499 (Sixth Circuit, 2014)
Lexon Insurance v. Devinshire Land Development, LLC
573 F. App'x 427 (Sixth Circuit, 2014)
Children's Legal Services, PLLC v. Shor Levin & Derita, PC
850 F. Supp. 2d 673 (E.D. Michigan, 2012)
Jones v. Dirty World Entertainment Recordings, LLC
766 F. Supp. 2d 828 (E.D. Kentucky, 2011)
PC Connection, Inc. v. Crabtree
754 F. Supp. 2d 317 (D. New Hampshire, 2010)
PC Connection v. Crabtree
2010 DNH 206 (D. New Hampshire, 2010)
Morris Aviation, LLC v. Diamond Aircraft Industries, Inc.
730 F. Supp. 2d 683 (W.D. Kentucky, 2010)
In Re Packaged Ice Antitrust Litigation
723 F. Supp. 2d 987 (E.D. Michigan, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
282 F.3d 883, 61 U.S.P.Q. 2d (BNA) 1845, 2002 U.S. App. LEXIS 3478, 2002 WL 341028, Counsel Stack Legal Research, https://law.counselstack.com/opinion/neogen-corporation-v-neo-gen-screening-inc-ca6-2002.